Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center.
Tan KL, Tan WS, Lim JF, Eu KW.
Int J Colorectal Dis. 2010 Feb;25(2):233-8. doi: 10.1007/s00384-009-0796-x. Epub 2009 Aug 25.
Similar articles
Krukenberg tumors from colorectal cancer: presentation, treatment and outcomes.
Ojo J, De Silva S, Han E, Lin P, Wakabayashi M, Nelson R, Lai LL.
Am Surg. 2011 Oct;77(10):1381-5.
Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
Sakakura C, Hagiwara A, Yamazaki J, Takagi T, Hosokawa K, Shimomura K, Kin S, Nakase Y, Fukuda K, Yamagishi H.
Hepatogastroenterology. 2004 Sep-Oct;51(59):1350-3.
Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.
Xu KY, Gao H, Lian ZJ, Ding L, Li M, Gu J.
World J Surg Oncol. 2017 Jan 14;15(1):25. doi: 10.1186/s12957-016-1087-y.
Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions.
Lee KC, Lin H, ChangChien CC, Fu HC, Tsai CC, Wu CH, Ou YC.
Taiwan J Obstet Gynecol. 2017 Feb;56(1):62-67. doi: 10.1016/j.tjog.2015.02.009.
[Krukenberg tumors of gastric origin versus Krukenberg tumors of colorectal origin].
Man M, Cazacu M, Oniu T.
Chirurgia (Bucur). 2007 Jul-Aug;102(4):407-10. Romanian.
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience.
Rosa F, Marrelli D, Morgagni P, Cipollari C, Vittimberga G, Framarini M, Cozzaglio L, Pedrazzani C, Berardi S, Baiocchi GL, Roviello F, Portolani N, de Manzoni G, Costamagna G, Doglietto GB, Pacelli F.
World J Surg. 2016 Apr;40(4):921-8. doi: 10.1007/s00268-015-3326-8.
Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I.
Trials. 2010 May 25;11:62. doi: 10.1186/1745-6215-11-62.
Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.
Mehta AM, Bignell MB, Alves S, Dayal SP, Mohamed F, Cecil TD, Moran BJ.
Dis Colon Rectum. 2017 Jul;60(7):691-696. doi: 10.1097/DCR.0000000000000791.
[Adnexal tumors after surgical treatment of colorectal cancer].
Gottwald L, Korczyński J, Góra E, Bieńkiewicz A.
Ginekol Pol. 2008 Apr;79(4):259-63. Polish.
Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall.
Lewis MR, Euscher ED, Deavers MT, Silva EG, Malpica A.
Gynecol Oncol. 2007 May;105(2):395-8. Epub 2007 Mar 1.
Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
Gynecol Oncol. 2000 Jul;78(1):16-20.
Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor.
Cho JH, Lim JY, Choi AR, Choi SM, Kim JW, Choi SH, Cho JY.
Cancer Res Treat. 2015 Oct;47(4):697-705. doi: 10.4143/crt.2013.175. Epub 2014 Nov 27. Erratum in: Cancer Res Treat. 2018 Jan;50(1):302.
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR, Huang Y, Liauw W, Zhao J, Morris DL.
Anticancer Res. 2016 Mar;36(3):1041-9.
Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.
Jiang R, Tang J, Cheng X, Zang RY.
Eur J Surg Oncol. 2009 Jan;35(1):92-7. doi: 10.1016/j.ejso.2008.05.006. Epub 2008 Jul 16.
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH, Jun KH, Jung H, Park IS, Chin HM.
Hepatogastroenterology. 2014 May;61(131):863-9.
Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.
Lee SJ, Lee J, Lim HY, Kang WK, Choi CH, Lee JW, Kim TJ, Kim BG, Bae DS, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Park YS.
Cancer Chemother Pharmacol. 2010 Jul;66(2):229-35. doi: 10.1007/s00280-009-1150-2. Epub 2009 Oct 10.
[Features of Krukenberg-type tumors--clinical study and review].
Mateş IN, Iosif C, Bănceanu G, Ionescu M, Peltecu G, Dinu D, Constantin A, Hoară P, Mitru C, Constantinoiu S.
Chirurgia (Bucur). 2008 Jan-Feb;103(1):23-38. Review. Romanian.
Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis.
Peng W, Hua RX, Jiang R, Ren C, Jia YN, Li J, Guo WJ.
PLoS One. 2013 Jul 9;8(7):e68227. doi: 10.1371/journal.pone.0068227. Print 2013.
Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL, Hui D, Hanson J, Butts C, Au HJ.
Clin Colorectal Cancer. 2008 Mar;7(2):118-25. doi: 10.3816/CCC.2008.n.016.
Filters: Manage Filters